Divi's Laboratories Limited (DIVISLAB.NS)
INR 5589.3
(3.77%)
INR 5589.3
(3.77%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 78.45 Billion INR | 1.0% |
| 2022 | 77.67 Billion INR | -11.73% |
| 2021 | 87.99 Billion INR | 28.3% |
| 2020 | 68.58 Billion INR | 29.62% |
| 2019 | 52.91 Billion INR | 10.15% |
| 2018 | 48.03 Billion INR | 26.17% |
| 2017 | 38.07 Billion INR | -6.07% |
| 2016 | 40.53 Billion INR | 7.33% |
| 2015 | 37.76 Billion INR | 21.23% |
| 2014 | 31.14 Billion INR | 23.02% |
| 2013 | 25.32 Billion INR | 18.06% |
| 2012 | 21.44 Billion INR | 15.06% |
| 2011 | 18.64 Billion INR | 42.61% |
| 2010 | 13.07 Billion INR | 38.82% |
| 2009 | 9.41 Billion INR | -92.02% |
| 2008 | 118.03 Billion INR | 1042.82% |
| 2007 | 10.32 Billion INR | 42.54% |
| 2006 | 7.24 Billion INR | 90.12% |
| 2005 | 3.81 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 19.09 Billion INR | 7.37% |
| 2023 FY | 78.45 Billion INR | 1.0% |
| 2023 Q4 | 21.18 Billion INR | -8.03% |
| 2023 Q3 | 23.03 Billion INR | 24.15% |
| 2023 Q2 | 18.55 Billion INR | -2.83% |
| 2022 Q3 | 19.5 Billion INR | 14.24% |
| 2022 Q1 | 18.54 Billion INR | -17.74% |
| 2022 FY | 77.67 Billion INR | -11.73% |
| 2022 Q2 | 17.07 Billion INR | -7.92% |
| 2022 Q4 | 17.78 Billion INR | -8.86% |
| 2021 Q2 | 24.93 Billion INR | 25.45% |
| 2021 Q4 | 22.54 Billion INR | -4.38% |
| 2021 Q3 | 23.57 Billion INR | -5.43% |
| 2021 Q1 | 19.87 Billion INR | 1.37% |
| 2021 FY | 87.99 Billion INR | 28.3% |
| 2020 Q3 | 16.77 Billion INR | -1.43% |
| 2020 FY | 68.58 Billion INR | 29.62% |
| 2020 Q4 | 19.6 Billion INR | 16.9% |
| 2020 Q2 | 17.01 Billion INR | -2.74% |
| 2020 Q1 | 17.49 Billion INR | 1.09% |
| 2019 Q1 | 14.45 Billion INR | 24.31% |
| 2019 Q3 | 12.86 Billion INR | -7.86% |
| 2019 Q4 | 17.3 Billion INR | 34.51% |
| 2019 FY | 52.91 Billion INR | 10.15% |
| 2019 Q2 | 13.96 Billion INR | -3.41% |
| 2018 Q2 | 13.59 Billion INR | 2.72% |
| 2018 FY | 48.03 Billion INR | 26.17% |
| 2018 Q4 | 11.62 Billion INR | 3.4% |
| 2018 Q3 | 11.24 Billion INR | -17.3% |
| 2018 Q1 | 13.23 Billion INR | 33.03% |
| 2017 FY | 38.07 Billion INR | -6.07% |
| 2017 Q4 | 9.95 Billion INR | 0.0% |
| 2016 FY | 40.53 Billion INR | 7.33% |
| 2015 FY | 37.76 Billion INR | 21.23% |
| 2014 Q3 | 8.18 Billion INR | 0.0% |
| 2014 FY | 31.14 Billion INR | 23.02% |
| 2013 FY | 25.32 Billion INR | 18.06% |
| 2013 Q3 | 7.47 Billion INR | 0.0% |
| 2012 Q3 | 6.55 Billion INR | 0.0% |
| 2012 FY | 21.44 Billion INR | 15.06% |
| 2011 FY | 18.64 Billion INR | 42.61% |
| 2010 FY | 13.07 Billion INR | 38.82% |
| 2009 FY | 9.41 Billion INR | -92.02% |
| 2008 FY | 118.03 Billion INR | 1042.82% |
| 2007 FY | 10.32 Billion INR | 42.54% |
| 2006 FY | 7.24 Billion INR | 90.12% |
| 2005 FY | 3.81 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -28.352% |
| Hester Biosciences Limited | 3.04 Billion INR | -2475.966% |
| Aarti Drugs Limited | 25.28 Billion INR | -210.254% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -332.111% |
| Albert David Limited | 3.62 Billion INR | -2064.367% |
| Alembic Limited | 1.57 Billion INR | -4881.417% |
| Alkem Laboratories Limited | 126.67 Billion INR | 38.07% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -5045.42% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -1557.098% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -19495.207% |
| Brooks Laboratories Limited | 794.86 Million INR | -9769.65% |
| Eris Lifesciences Limited | 20.09 Billion INR | -290.465% |
| FDC Limited | 19.42 Billion INR | -303.769% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -243.595% |
| Gufic Biosciences Limited | 8.06 Billion INR | -872.522% |
| Hikal Limited | 17.84 Billion INR | -339.594% |
| Ind-Swift Limited | 5.02 Billion INR | -1461.293% |
| Innova Captab Limited | 10.81 Billion INR | -625.512% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -267.828% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -3658.948% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -17.039% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -1251.306% |
| Lupin Limited | 196.56 Billion INR | 60.089% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -2035.545% |
| Medico Remedies Limited | 1.44 Billion INR | -5313.305% |
| Morepen Laboratories Limited | 17.01 Billion INR | -360.956% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -365.697% |
| Orchid Pharma Limited | 8.19 Billion INR | -857.445% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -581.427% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1247.822% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -4981.864% |
| Sigachi Industries Limited | 3.98 Billion INR | -1866.382% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -533.484% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -646.181% |
| Themis Medicare Limited | 3.81 Billion INR | -1954.952% |
| Unichem Laboratories Limited | 16.57 Billion INR | -373.327% |
| Vaishali Pharma Limited | 862.79 Million INR | -8992.521% |
| Wanbury Limited | 5.75 Billion INR | -1262.808% |
| Windlas Biotech Limited | 6.3 Billion INR | -1143.351% |
| ZIM Laboratories Limited | 3.67 Billion INR | -2034.595% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -512.46% |
| Ipca Laboratories Limited | 77.05 Billion INR | -1.805% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 83.824% |
| Venus Remedies Limited | 5.91 Billion INR | -1226.402% |
| Sakar Healthcare Limited | 1.54 Billion INR | -4988.628% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 72.95% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -505.544% |
| Mankind Pharma Limited | 103.34 Billion INR | 24.091% |
| Sequent Scientific Limited | 13.69 Billion INR | -472.74% |
| Laurus Labs Limited | 50.01 Billion INR | -56.844% |
| Neuland Laboratories Limited | 15.58 Billion INR | -403.343% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -127.545% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 33.591% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 58.757% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -1762.401% |
| Wockhardt Limited | 27.89 Billion INR | -181.284% |
| Bal Pharma Limited | 3.39 Billion INR | -2212.661% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 71.898% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -918.507% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -8102.601% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -367.861% |
| Shilpa Medicare Limited | 11.53 Billion INR | -580.336% |
| Valiant Laboratories Limited | 1.82 Billion INR | -4209.085% |
| Ajanta Pharma Limited | 42.08 Billion INR | -86.399% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -1882.974% |
| Granules India Limited | 45.06 Billion INR | -74.087% |
| Medicamen Biotech Limited | 1.79 Billion INR | -4275.197% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -2926.107% |
| Piramal Enterprises Limited | 60.33 Billion INR | -30.019% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 26.028% |
| NATCO Pharma Limited | 40.02 Billion INR | -96.027% |
| Suven Life Sciences Limited | 116.92 Million INR | -66991.996% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -15458.839% |
| Strides Pharma Science Limited | 40.51 Billion INR | -93.65% |
| Indoco Remedies Limited | 18.17 Billion INR | -331.687% |
| Alpa Laboratories Limited | 1.08 Billion INR | -7114.523% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -7419.049% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -10284.498% |